Likes
Job security is horrible, work culture is poor, management has no view of employees welfare. HR policy and company policy is completely poor.
read moreCompany name | Avg Annual Salary | Open Jobs |
---|---|---|
Biocon Limited Executive Quality Assurance Salary
1 - 6 years exp. (25 salaries) | ₹3.6 L/yr - ₹5.5 L/yr
9%
more | |
Sun Pharmaceutical Industries Executive Quality Assurance Salary
5 - 12 years exp. (71 salaries) | ₹4.2 L/yr - ₹10 L/yr
88%
more | |
Login to view exact salary
| ||
Cipla Executive Quality Assurance Salary
2 - 6 years exp. (12 salaries) | ₹3.5 L/yr - ₹4.5 L/yr At par | |
DIVI'S Laboratories Executive Quality Assurance Salary
2 - 4 years exp. (5 salaries) | ₹2.9 L/yr - ₹4.4 L/yr
2%
less | |
Lupin Executive Quality Assurance Salary
4 - 12 years exp. (131 salaries) | ₹3.9 L/yr - ₹11.5 L/yr
73%
more | |
Torrent Pharmaceuticals Executive Quality Assurance Salary
1 - 14 years exp. (74 salaries) | ₹2.8 L/yr - ₹10.1 L/yr
39%
more | |
Zydus Lifesciences Executive Quality Assurance Salary
2 - 8 years exp. (53 salaries) | ₹3 L/yr - ₹7.3 L/yr
23%
more | |
Glenmark Pharmaceuticals Executive Quality Assurance Salary
6 - 12 years exp. (38 salaries) | ₹4.8 L/yr - ₹9.6 L/yr
85%
more | |
Recipharm Pharmaservices Executive Quality Assurance Salary
0 - 6 years exp. (10 salaries) | ₹2.7 L/yr - ₹4.5 L/yr
10%
less | |
Oman Pharmaceutical Products Executive Quality Assurance Salary
5 - 10 years exp. (7 salaries) | ₹7.5 L/yr - ₹10 L/yr
122%
more | |
Wexford Laboratories Executive Quality Assurance Salary
1 - 5 years exp. (5 salaries) | ₹1.5 L/yr - ₹4 L/yr
31%
less | |
Login to view exact salary
| ||
Stanford Laboratories Executive Quality Assurance Salary
4 - 7 years exp. (3 salaries) | ₹3.6 L/yr - ₹4.6 L/yr At par | |
Nuray Chemicals Executive Quality Assurance Salary
1 - 5 years exp. (3 salaries) | ₹2 L/yr - ₹3.2 L/yr
31%
less | |
Tirupati Life Sciences Executive Quality Assurance Salary
4 - 5 years exp. (3 salaries) | ₹4.5 L/yr - ₹5.6 L/yr
20%
more | |
Discover interview dos and don'ts from real experiences
Top trending discussions